2-Methyl-6-(phenylethynyl)pyridine
Chemical compound
2-Methyl-6-(phenylethynyl)pyridine (MPEP) is a chemical compound that acts as a selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5). It is used primarily in scientific research to study the role of mGluR5 in various physiological and pathological processes.
Chemical structure and properties
2-Methyl-6-(phenylethynyl)pyridine is a derivative of pyridine, a basic heterocyclic organic compound. The structure of MPEP includes a pyridine ring substituted with a methyl group at the 2-position and a phenylethynyl group at the 6-position. This specific substitution pattern is crucial for its activity as an mGluR5 antagonist.
Mechanism of action
MPEP functions by selectively binding to the mGluR5 receptor, inhibiting its activity. The mGluR5 receptor is a member of the group I metabotropic glutamate receptors, which are G-protein coupled receptors involved in modulating synaptic transmission and plasticity in the central nervous system. By blocking mGluR5, MPEP can modulate glutamatergic signaling, which is implicated in various neurological and psychiatric disorders.
Applications in research
MPEP is widely used in neuroscience research to investigate the role of mGluR5 in conditions such as anxiety, depression, schizophrenia, and Parkinson's disease. It has also been studied for its potential therapeutic effects in fragile X syndrome, a genetic disorder characterized by intellectual disability and behavioral challenges.
Pharmacological effects
In preclinical studies, MPEP has been shown to produce anxiolytic and antidepressant-like effects in animal models. It also exhibits neuroprotective properties, making it a valuable tool for exploring the therapeutic potential of mGluR5 antagonism in neurodegenerative diseases.
Safety and toxicity
As with many research chemicals, the safety and toxicity profile of MPEP in humans is not well-established. It is primarily used in laboratory settings under controlled conditions to minimize potential risks.
Related pages
Gallery
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD